Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury

Neuroscience

Volumn 99, Issue 1, 2000, Pages 189-197

  Abraham, K E ^a   Brewer, K L ^a   McGinty, J F ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Dynorphin; Enkephalin; Excitotoxicity; Pain; Quisqualic acid; Spinal cord injury

Indexed keywords

MESSENGER RNA; OPIATE PEPTIDE; PREPRODYNORPHIN; PREPROENKEPHALIN; QUISQUALIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; THALAMUS;

ANIMALS; DYNORPHINS; ENKEPHALINS; EXCITATORY AMINO ACID AGONISTS; LUMBAR VERTEBRAE; MALE; OPIOID PEPTIDES; PROTEIN PRECURSORS; QUISQUALIC ACID; RATS; RATS, LONG-EVANS; RNA, MESSENGER; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 0034718197     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00150-0     Document Type: Article

References (54)

1. Alvarez-Bolado G., Fairen A., Douglass J., Naranjo J.R. Expression of the prodynorphin gene in the developing and adult cerebral cortex of the rat: an in situ hybridization study. J. comp. Neurol. 300:1990;287-300.
2. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight drop device versus transection. Expl Neurol. 137:1996;244-256.
3. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rats that produces disorders of pain sensation like those seen in humans. Pain. 33:1988;87-107.
4. Beric A., Dimitrijevic M., Lindblom U. Central dysesthesia syndrome in SCI patients. Pain. 34:1988;109-116.
5. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-κB activation. J. Neurosci. 18:1998;3251-3260.
6. Brewer K.L., Yezierski R.P., Bethea J.R. Excitotoxic spinal cord injury induces diencephalic changes in gene expression. Soc. Neurosci. Abstr. 23:(part 1):1997;438.
7. Christensen M.D., Everhart A.W., Pickelman J., Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain. 68:1996;97-107.
8. Davidoff G., Roth E., Guarracini M., Sliwa J., Yarkony G. Function-limiting dysesthetic pain syndrome among traumatic spinal cord injury patients: a cross-sectional study. Pain. 29:1987;39-48.
9. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Upregulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
10. Faden A.I., Molineaux C.J., Rosenberger J.G., Jacobs T.P., Cox B.M. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury. Ann. Neurol. 17:1985a;386-390.
11. Faden A.I., Molineaux C.J., Rosenberger J.G., Jacobs T.P., Cox B.M. Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regul. Pept. 11:1985b;35-41.
12. Faden A.I. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann. Neurol. 27:1990;67-74.
13. Gaumann D.M., Grabow T.S., Yaksh T.L., Casy S.J., Rodriguez M. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats. Neuropharmacology. 39:1990;761-774.
14. Hao J.-X., Xu X.-J., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Allodynia-like effects in rat after ischemic spinal cord injury photochemically induced by laser irradiation. Pain. 45:1991;175-185.
15. Harlan R.E., Shivers B.D., Romano G.J., Howells R.D., Pfaff D.W. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J. comp. Neurol. 258:1987;159-184.
16. Helton T., McGinty J. Intrahippocampal NMDA administration alters fos, fos-related antigens and opioid peptide immunoreactivity and mRNA in rats. Molec. cell. Neurosci. 4:1993;319-334.
17. Hurd Y.L. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience. 72:1996;767-783.
18. Kenshalo D. R. and Willis W. D. (1991) The role of the cerebral cortex in pain sensation. In Cerebral Cortex (eds Peters A. and Jones E. G.), Vol. 9. Plenum, New York.
19. Kosterlitz H.V. Opioid peptides and their receptors. Proc. R. Soc. Lond. 225B:1985;27-40.
20. Lenz F.A., Kwan H.C., Martin R., Tasker R., Dostrovsky J.O. Characteristics of spontaneous neuronal activity at different locations in ventrocaudal thalamus of patients with central pain following spinal cord transaction. Pain, Suppl. 5:1990;493.
21. Levitt M. Dysesthesias and self-mutilation in humans and subhumans: a review of clinical and experimental studies. Brain Res. Rev. 10:1985;247-290.
22. Liu S., Ruenes G., Yezierski R. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res. 756:1997;160-167.
23. Long J.B., Rigamonti D.R., deCosta B., Rice K.C., Martinez-Arizala A. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the κ-opioid antagonist nor-binaltorphimine. Brain Res. 497:1989;155-162.
24. McGinty J.F., van der Kooy D., Bloom F.E. The distribution and morphology of opioid peptide immunoreactive neurons in the cerebral cortex of rats. J. Neurosci. 4:1984;1104-1117.
25. Melzack R. and Casey K. L. (1968) Sensory, motivational and central control of determinants of pain. A new conceptual model. In The Skin Senses (ed Kenshalo D. R.). Thomas, Springfield, pp. 423-439.
26. Melzack R., Loeser J. Phantom body pain in paraplegics: evidence for a central "pattern generating mechanism" for pain. Pain. 4:1978;195-210.
27. Millan M.J. Multiple opioid systems and pain. Pain. 27:1986;303-349.
28. Morrow T.J., Paulson P.E., Casey K.L., Brewer K.L., Yezierski R.P. Cortical and subcortical changes in blood flow following excitotoxic spinal cord injury. Expl Neurol. 161:2000;220-226.
29. Noguchi K., Dubner R., Ruda M.A. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with fos and fos-related proteins. Neuroscience. 46:1992;561-570.
30. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Molec. Brain Res. 10:1991;227-233.
31. Olsson Y., Sharma H.S., Nyberg F., Westman J. The opioid receptor antagonist naloxone influences the pathophysiology of spinal cord injury. Prog. Brain Res. 104:1995;381-399.
32. Przewlocki R., Haarmann I., Nikolarakis K., Herz A., Hollt V. Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Brain Res. 464:1988;37-41.
33. Reep R., Winans S. Afferent connections of dorsal and ventral agranular insular cortex in the hamster Mesocricetus auratus. Neuroscience. 7:1982;1265-1288.
34. Ruda M.A., Iadarola M.J., Cohen L.V., Young W.S. III. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc. natn. Acad. Sci. USA. 85:1988;622-626.
35. Ruda M., Ren K., Besse D. Regulation of spinal neuropeptide genes in a rat model of peripheral inflammation and hyperalgesia. Prog. Brain Res. 104:1995;349-365.
36. Sharma H.S., Nyberg F., Olsson Y. Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neurosci. Res. 14:1992;195-203.
37. Sharma H.S., Nyberg F., Thomwall M., Olsson Y. Met-Enkephalin-Arg 6-Phe 7 in spinal cord and brain following traumatic injury to the spinal cord: influence of p-chlorophenylalanine. An experimental study in the rat using radioimmunoassay technique. Neuropharmacology. 32:1993;711-717.
38. Sharma H.S., Nyberg G., Olsson Y. Topical application of dynorphin-A antibodies reduces edema and cell changes in traumatised rat spinal cord. Regul. Pept., Suppl. 1:1994;S91-S92.
39. Siddall P.J., Taylor D.A., Cousins M.J. Classification of pain following spinal cord injury. Spinal Cord. 35:1997;69-75.
40. Siddall P.J., Xu C.L., Cousins M. Allodynia following traumatic spinal cord injury in the rat. NeuroReport. 6:1995;1241-1244.
41. Smith A.P., Lee N.M. Pharmacology of dynorphin. A. Rev. Pharmac. Toxic. 28:1988;123-140.
42. Smith A., McGinty J. Acute amphetamine or metamphetamine alters opioid peptide mRNA expression in rat striatum. Molec. Brain Res. 21:1994;359-362.
43. Tachibana T., Miki K., Fukuoka T., Arakawa A., Taniguchi M., Maruo S., Noguchi K. Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. J. Neurotrauma. 15:1998;485-494.
44. Tasker R. R., de Carvallo G. and Dostrovsky J. O. (1991) The history of central pain syndromes, with observations concerning pathophysiology and treatment. In Pain and Central Nervous System Disease: The Central Pain Syndromes (ed Casey K. L.). Raven, New York, pp. 31-58.
45. Tunks E. (1986) Pain in spinal cord injured patients. In Management of Spinal Cord Injuries (eds Block R. F. and Basbaum M.). William & Wilkins, Baltimore, MD, pp. 180-211.
46. Vogt B. A., Sikes R. W. and Vogt L. J. (1993) Anterior cingulate cortex and the medial pain system. In Neurobiology of Cingulate Cortex and Limbic Thalamus (eds Vogt B. A. and Gabriel M.). Birkhauser, Boston, pp. 313-344.
47. Wang J., McGinty J. Dose-dependent alteration in zif-268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmac. exp. Ther. 273:1995;909-917.
48. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 362:1993;423-427.
49. Yakovlev A.G., Faden A.I. Sequential expression of c-fos protooncogene, TNF-α, and dynorphin genes in spinal cord following experimental traumatic injury. Molec. chem. Neuropath. 23:1994;179-190.
50. Yezierski R.P., Park S.H. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci. Lett. 157:1993;115-119.
51. Yezierski R.P., Santana M., Park S.H., Madsen P.W. Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. J. Neurotrauma. 10:1993;445-456.
52. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 68:1996;185-194.
53. Yezierski R.P., Liu S., Ruenes G.L., Kajander K.J., Brewer K.L. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain. 75:1998;141-155.
54. Zeltser R. and Seltzer Z. (1994) A practical guide for the use of animal models in the study of neuropathic pain. In Touch, Temperature, and Pain in Health and Disease: Mechanisms and Assessments; Progress in Pain Research and Management (eds Boivie J., Hanson P. and Lindbolm U.), Vol. 3. IASP, Seattle, pp. 295-338.